LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
42.01
+3.92 (10.29%)
At close: Nov 6, 2026, 4:00 PM EST
42.63
+0.62 (1.48%)
After-hours: Nov 6, 2026, 7:53 PM EST
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $1.36 billion as of November 6, 2026. It is the 8,873rd most valuable company in the world and the 2,081st biggest in the United States. Its market cap has increased by 272.74% in one year.
Market Cap
1.36B
Enterprise Value
956.60M
1-Year Change
272.74%
Global Rank
Country Rank
#2,081 United States
Category
ChartMarket Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $1.36B, an increase of 349.49%. That is a compound annual growth rate of 268.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.36B | 140.64% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.41B |
| UroGen Pharma | 1.40B |
| Korsana Biosciences | 1.38B |
| GH Research | 1.36B |
| Omeros | 1.32B |
| Nektar Therapeutics | 1.30B |
| Alpha Tau Medical | 1.30B |
| Ascentage Pharma Group International | 1.28B |